Eikon Therapeutics Inc. Common Stock logo

Eikon Therapeutics Inc. Common Stock

EIKN | NASDAQ
Chart Builder DCF Calculator
$5.31
-$0.04 (-0.75%)
At close: Oct 30, 2026, 4:00 PM ET
$5.49
+$0.18 (+3.39%)
Pre-market: Nov 2, 2026, 4:00 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
Net Income
-324.25M
Depreciation & Amortization
24.18M
Stock-Based Compensation
18.04M
Other Working Capital
81.65M
Other Non-Cash Items
15.69M
Deferred Income Tax
n/a
Change in Working Capital
77.84M
Operating Cash Flow
-188.52M
Capital Expenditures
-46.74M
Cash Acquisitions
n/a
Purchase of Investments
-444.1M
Sales Maturities Of Investments
309.5M
Other Investing Acitivies
n/a
Investing Cash Flow
-181.34M
Debt Repayment
n/a
Common Stock Repurchased
n/a
Dividend Paid
n/a
Other Financial Acitivies
n/a
Financial Cash Flow
352.05M
Net Cash Flow
-17.81M
Free Cash Flow
-235.26M
Adj. Free Cash Flow
-253.29M
Maintenance CapEx
-24.18M
Growth CapEx
-22.57M
Owner Earnings
-212.69M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.